炎症性肠病相关贫血的研究现状
Research Status of Anemia Associated with Inflammatory Bowel Disease
摘要: 炎症性肠病(IBD)是一类慢性胃肠道炎症性疾病，包括溃疡性结肠炎(UC)和罗恩病(CD)，IBD并不局限于胃肠道，还可以累及全身多个系统，在全球范围内其发病率及患病率逐年上升。贫血是IBD患者一种常见且严重的并发症。IBD相关贫血的病因多种多样，其中最常见的类型是缺铁性贫血(IDA)、慢性病贫血(ACD)是IBD。IBD相关贫血的严重程度及治疗会影响患者的生活质量及疾病转归。本文从IBD相关贫血的类型、发病机制及治疗等方面作一综述。
Abstract: Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory disorders of the gastrointestinal tract, encompassing ulcerative colitis (UC) and Crohn’s disease (CD). IBD is not merely restricted to the gastrointestinal system; rather, it can involve multiple systemic organs. Globally, both the incidence and prevalence of IBD have been on the rise in recent years. Anemia is a prevalent and severe complication among patients with IBD. The etiologies of IBD-related anemia are multifaceted. Among them, the most common types are iron deficiency anemia (IDA) and anemia of chronic disease (ACD) associated with IBD. The severity of IBD-related anemia and its treatment strategies significantly impact the quality of life and disease prognosis of patients. This article aims to comprehensively review various aspects of IBD-related anemia, including its types, pathogenesis, and treatment modalities.
文章引用：孙莉娟, 陈力, 李倩. 炎症性肠病相关贫血的研究现状[J]. 临床个性化医学, 2025, 4(3): 712-718. https://doi.org/10.12677/jcpm.2025.43400

参考文献

[1] Danpanichkul, P., Duangsonk, K., Ho, A.H.Y., et al. (2025) Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Female Patients and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021. The American Journal of Gastroenterology, 120, 675-680. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, S., Dong, Z. and Wan, X. (2024) Global, Regional, and National Burden of Inflammatory Bowel Disease and Its Associated Anemia, 1990 to 2019 and Predictions to 2050: An Analysis of the Global Burden of Disease Study 2019. Autoimmunity Reviews, 23, Article 103498. [Google Scholar] [CrossRef] [PubMed]
[3] Aniwan, S., Santiago, P., Loftus, E.V. and Park, S.H. (2022) The Epidemiology of Inflammatory Bowel Disease in Asia and Asian Immigrants to Western Countries. United European Gastroenterology Journal, 10, 1063-1076. [Google Scholar] [CrossRef] [PubMed]
[4] Giri, S., Jena, A., Kumar-M, P., Muniswamy, J.R., Nath, P. and Sharma, V. (2025) Burden of Inflammatory Bowel Disease in India: Analysis of the Global Burden of Disease Study from 1990 to 2019. Intestinal Research. Ahead-of Print. [Google Scholar] [CrossRef] [PubMed]
[5] Katayama, E.S., Woldesenbet, S., Tsilimigras, D., Munir, M.M., Endo, Y., Huang, E., et al. (2024) Inflammatory Bowel Disease-Associated Colorectal Cancer Negatively Affects Surgery Outcomes and Health Care Costs. Surgery, 176, 32-37. [Google Scholar] [CrossRef] [PubMed]
[6] Burisch, J., Hart, A., Sturm, A., et al. (2025) Residual Disease Burden Among European Patients with Inflammatory Bowel Disease: A Real-World Survey. Inflammatory Bowel Diseases, 31, 411-424. [Google Scholar] [CrossRef] [PubMed]
[7] Shiratori, Y., Hutfless, S., Rateb, G. and Fukuda K. (2023) The Burden of Gastrointestinal Diseases in Japan, 1990-2019, and Projections for 2035. JGH Open, 7, 221-227. [Google Scholar] [CrossRef] [PubMed]
[8] Aebisher, D., Bartusik-Aebisher, D., Przygórzewska, A., Oleś, P., Woźnicki, P. and Kawczyk-Krupka, A. (2024) Key Interleukins in Inflammatory Bowel Disease-A Review of Recent Studies. International Journal of Molecular Sciences, 26, Article 121. [Google Scholar] [CrossRef] [PubMed]
[9] Woźniak, M., Borkowska, A., Jastrzębska, M., Sochal, M., Małecka-Wojciesko, E. and Talar-Wojnarowska, R. (2023) Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine, 12, Article 2447. [Google Scholar] [CrossRef] [PubMed]
[10] D’Arcangelo, G., Brecciaroli, M., Gagliostro, G., Auletta, D., Pellegrino, S., Arrigo, S., et al. (2025) Prevalence and Trend of Anemia in Children with Inflammatory Bowel Disease: A National Register‐Based Cohort Study. Journal of Pediatric Gastroenterology and Nutrition, 80, 967-978. [Google Scholar] [CrossRef] [PubMed]
[11] Maas, L.A., Krishna, M. and Parian, A.M. (2023) Ironing It All Out: A Comprehensive Review of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences, 68, 357-369. [Google Scholar] [CrossRef] [PubMed]
[12] Xue, M., Chen, J., Zheng, W., Liu, Y., Lin, Y. and Wang, C. (2023) Clinical Characteristics and Quality of Life in Patients with Inflammatory Bowel Disease-Associated Anemia in Southeast China. European Journal of Gastroenterology & Hepatology, 35, 275-284. [Google Scholar] [CrossRef] [PubMed]
[13] Hsiao, P., Weng, M., Chang, C., Huang, L., Tung, C., Leong, Y., et al. (2023) Anemia in Inflammatory Bowel Disease Course Is Associated with Patients’ Worse Outcome. Journal of the Formosan Medical Association, 122, 549-556. [Google Scholar] [CrossRef] [PubMed]
[14] Stratmann, K., Hentschel, V., Zeuzem, S., Blumenstein, I. and Klaus, J. (2024) Eisensupplementation bei patienten mit chronisch-entzündlicher Darmerkrankung: Empfehlungen zur praxisnahen Vorgehensweise. Zeitschrift für Gastroenterologie, 62, 1389-1396. [Google Scholar] [CrossRef] [PubMed]
[15] Marques, O., Weiss, G. and Muckenthaler, M.U. (2022) The Role of Iron in Chronic Inflammatory Diseases: From Mechanisms to Treatment Options in Anemia of Inflammation. Blood, 140, 2011-2023. [Google Scholar] [CrossRef] [PubMed]
[16] Lei, H., Shawki, A., Santos, A.N., et al. (2025) PTPN2 Regulates Iron Handling Protein Expression in Inflammatory Bowel Disease Patients and Prevents Iron Deficiency in Mice. International Journal of Molecular Sciences, 26, Article 3356. [Google Scholar] [CrossRef] [PubMed]
[17] Petrović, S., Tarabar, D., Ćujić, D., et al. (2024) A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases. International Journal of Molecular Sciences, 25, Article 3564. [Google Scholar] [CrossRef] [PubMed]
[18] Ferrari, F., Carini, M., Zanella, I., et al. (2024) Potential Diagnostic Role of Hepcidin in Anemic Patients Affected by Inflammatory Bowel Disease: A Systematic Review. Diagnostics, 14, Article 375. [Google Scholar] [CrossRef] [PubMed]
[19] Cappellini, M.D., Scaramellini, N. and Motta, I. (2023) Iron Status in Chronic Inflammatory Disease: Therapeutic Implications. Polish Archives of Internal Medicine, 133, Article 16430. [Google Scholar] [CrossRef] [PubMed]
[20] Dutta, A.K., Chinthala, H., George, J.T., Thomas, D.M. and Joseph Joseph, A. (2025) Anemia in Inflammatory Bowel Disease—A Comprehensive Review. Indian Journal of Gastroenterology. [Google Scholar] [CrossRef] [PubMed]
[21] Xiao, P., Cai, X., Zhang, Z., et al. (2024) Butyrate Prevents the Pathogenic Anemia-Inflammation Circuit by Facilitating Macrophage Iron Export. Advanced Science, 11, Article e2306571. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, J., Guay, H. and Chang, D. (2024) Crohn’s Disease and Ulcerative Colitis Share 2 Molecular Subtypes with Different Mechanisms and Drug Responses. Journal of Crohn’s and Colitis, 19, jjae152. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, M., Zheng, C., Zhou, F., et al. (2025) Iron and Inflammatory Cytokines Synergistically Induce Colonic Epithelial Cell Ferroptosis in Colitis. Journal of Gastroenterology and Hepatology, 40, 666-676. [Google Scholar] [CrossRef] [PubMed]
[24] Bergamaschi, G., Castiglione, F., D’Incà, R., et al. (2024) Follow-up Evaluation and Management of Anemia in Inflammatory Bowel Disease: A Study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD). Digestive and Liver Disease, 56, 1483-1489. [Google Scholar] [CrossRef] [PubMed]
[25] Martinelli, M., Fioretti, M.T., Aloi, M., et al. (2024) Diagnosis and Management of Anemia in Pediatric Inflammatory Bowel Diseases: Clinical Practice Guidelines on Behalf of the SIGENP IBD Working Group. Digestive and Liver Disease, 56, 1257-1269. [Google Scholar] [CrossRef] [PubMed]
[26] Okuyucu, M., Avcioğlu, U., Şenel, T. and Ustaoğlu, M. (2022) Investigation of the Effects of Anti-TNF Agents on Hemoglobin Levels in Patients with Inflammatory Bowel Disease. Medicine, 101, e30118. [Google Scholar] [CrossRef] [PubMed]
[27] Lindgren, S.C., Strid, H., Hjortswang, H., Manxhuka, B., Nanu, N. and Pollock, R.F. (2025) A Swedish Cost-Utility Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease. Journal of Medical Economics, 28, 567-575. [Google Scholar] [CrossRef] [PubMed]
[28] Iqbal, T.H., Kennedy, N., Dhar, A., Ahmed, W. and Pollock, R.F. (2024) Cost-Utility Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in England. Journal of Medical Economics, 27, 392-403. [Google Scholar] [CrossRef] [PubMed]
[29] Ma, B., Hu, X., Ai, X. and Zhang, Y. (2024) Research Progress of Ferroptosis and Inflammatory Bowel Disease. BioMetals, 37, 1063. [Google Scholar] [CrossRef] [PubMed]